Filter By Category
Archives
Share on -
ATILOTREVIR
Generic Name: ATILOTREVIR
ABSTRACT -
Atilotrevir is a small-molecule antiviral protease inhibitor also reported in public sources as atilotrelvir or GST-HG171. It targets the SARS-CoV-2 main protease/3CL protease and has been developed for treatment of coronavirus disease in combination-based antiviral regimens. It has a discrete chemical structure and molecular formula C24H32F3N5O4.
This document is for structured API information only. It is not a prescribing guide. Clinical use, if any, must follow the approved local label, trial protocol, and specialist medical supervision.
DOSAGE -
- Dosage should be determined only by a qualified healthcare professional.
- Use only according to the approved local label or clinical-trial protocol.
- When used with pharmacokinetic boosters such as ritonavir, dosing and interaction review are essential.
- Renal and hepatic function should be considered before treatment.
SIDE EFFECTS–
Possible side effects and safety concerns include:
- Nausea, diarrhea, abdominal discomfort, or altered taste
- Headache, fatigue, or dizziness
- Liver enzyme elevations may occur
- Rash or pruritus
- Serious hypersensitivity reactions are uncommon but possible.
ALLERGIC REACTIONS -
Hypersensitivity to Atilotrevir or related compounds/products may occur. Symptoms may include:
- Immediate urticaria or generalized rash
- Facial, lip, tongue, or throat swelling
- Wheezing or breathing difficulty
- Dizziness, collapse, or anaphylaxis
Important: Patients who develop an allergic reaction to Atilotrevir should seek immediate medical attention and inform all future healthcare providers of the allergy.
DRUG INTERACTIONS-
Atilotrevir may interact with certain medicines, protocols, vaccines, clinical conditions, or procedures. Caution is needed with:
- Ritonavir-containing regimens have major CYP3A-related interaction potential.
- Avoid or adjust strong CYP3A inducers or contraindicated substrates as directed by label.
- Review anticoagulants, antiarrhythmics, anticonvulsants, transplant medicines, and statins carefully.
- Other antivirals or investigational agents require protocol review.
Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.
PREAUTIONS–
- Confirm indication, timing from symptom onset, and viral-disease management plan.
- Review liver disease, kidney disease, and all current medicines before use.
- Monitor clinically for treatment failure, adverse reactions, and rebound symptoms if applicable.
- Pregnancy and lactation use should follow local label and specialist advice.
WARNINGS –
- Drug interaction screening is critical before use.
- Do not use outside the approved label or trial protocol.
- Seek urgent care for severe allergic reaction, jaundice, or breathing difficulty.
- Keep out of reach of children.
Share on -
. Developed by